©2022 Stanford Medicine
COVID-19 in Patients With Chronic Liver Diseases
Not Recruiting
Trial ID: NCT04439084
Purpose
This study seeks to determine how COVID-19 affects the clinical outcome of patients with
chronic liver disease, and whether the clinical course of COVID-19 is influenced by
underlying chronic liver disease.
Official Title
COVID-19 in Patients With Chronic Liver Diseases
Stanford Investigator(s)
Renumathy Dhanasekaran
Assistant Professor of Medicine (Gastroenterology)
Eligibility
Inclusion Criteria:
- Confirmed diagnosis of COVID-19
- Personal history of either
- Chronic hepatitis C
- Chronic hepatitis B
- Alcoholic liver disease
- Non alcoholic liver disease
- Autoimmune hepatitis, Primary biliary cholangitis, Primary sclerosing cholangitis
- Cryptogenic cirrhosis
- Hepatocellular carcinoma
Exclusion Criteria:
- Non-COVID-19 patient
Intervention(s):
other: Prospective Chart Review
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305